Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant for pruritus after burn injury
NCT02975271Phase 2Terminated
- Sponsor
- Vyne Therapeutics
- Start
- Nov 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of serlopitant in pruritus, sponsored by Vyne Therapeutics. Started Nov 2016; status: terminated.
02
Drugs
serlopitant
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT02975271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975271.